Search research articles
Contact Us
Filters
Showing results (1-10 of 72) with videos related to
Page
of 8
Sort By:
Current Drug Targets
|
June 30, 2010
Molecular targeting of aberrant transcription factors in leukemia: strategies for RUNX1/ETO
Christian Wichmann, Manuel Grez, Jörn Lausen
Biomed Research International
|
July 19, 2013
Interference with RUNX1/ETO leukemogenic function by cell-penetrating peptides targeting the NHR2 oligomerization domain
Yvonne Bartel, Manuel Grez, Christian Wichmann
ACS Synthetic Biology
|
September 30, 2014
Conditional control of mammalian gene expression by tetracycline-dependent hammerhead ribozymes
Kim Beilstein, Alexander Wittmann, Manuel Grez, et al.
Journal of Chemical Information and Modeling
|
August 21, 2013
From determinants of RUNX1/ETO tetramerization to small-molecule protein-protein interaction inhibitors targeting acute myeloid leukemia
Alexander Metz, Julia Schanda, Manuel Grez, et al.
Molecular Therapy. Methods & Clinical Development
|
May 28, 2015
Generation of X-CGD cells for vector evaluation from healthy donor CD34(+) HSCs by shRNA-mediated knock down of gp91(phox)
Christian Brendel, Kerstin B Kaufmann, Anja Krattenmacher, et al.
Gene Therapy
|
March 23, 2021
Retroviral gene therapy in Germany with a view on previous experience and future perspectives
Michael A Morgan, Melanie Galla, Manuel Grez, et al.
Nucleic Acids Research
|
February 9, 2018
A small, portable RNA device for the control of exon skipping in mammalian cells
Marc Vogel, Julia E Weigand, Britta Kluge, et al.
EMBO Molecular Medicine
|
October 10, 2013
Gene therapy on the move
Kerstin B Kaufmann, Hildegard Büning, Anne Galy, et al.
Current Gene Therapy
|
June 23, 2007
Advances in the treatment of Chronic Granulomatous Disease by gene therapy
Marion G Ott, Reinhard Seger, Stefan Stein, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
November 4, 2010
Gene therapy of chronic granulomatous disease: the engraftment dilemma
Manuel Grez, Janine Reichenbach, Joachim Schwäble, et al.
Page
of 8
Search research articles
Search
Showing results (1-10 of 72) with videos related to
Sort By:
Page
of 8
Current Drug Targets
|
June 30, 2010
Molecular targeting of aberrant transcription factors in leukemia: strategies for RUNX1/ETO
Christian Wichmann, Manuel Grez, Jörn Lausen
Biomed Research International
|
July 19, 2013
Interference with RUNX1/ETO leukemogenic function by cell-penetrating peptides targeting the NHR2 oligomerization domain
Yvonne Bartel, Manuel Grez, Christian Wichmann
ACS Synthetic Biology
|
September 30, 2014
Conditional control of mammalian gene expression by tetracycline-dependent hammerhead ribozymes
Kim Beilstein, Alexander Wittmann, Manuel Grez, et al.
Journal of Chemical Information and Modeling
|
August 21, 2013
From determinants of RUNX1/ETO tetramerization to small-molecule protein-protein interaction inhibitors targeting acute myeloid leukemia
Alexander Metz, Julia Schanda, Manuel Grez, et al.
Molecular Therapy. Methods & Clinical Development
|
May 28, 2015
Generation of X-CGD cells for vector evaluation from healthy donor CD34(+) HSCs by shRNA-mediated knock down of gp91(phox)
Christian Brendel, Kerstin B Kaufmann, Anja Krattenmacher, et al.
Gene Therapy
|
March 23, 2021
Retroviral gene therapy in Germany with a view on previous experience and future perspectives
Michael A Morgan, Melanie Galla, Manuel Grez, et al.
Nucleic Acids Research
|
February 9, 2018
A small, portable RNA device for the control of exon skipping in mammalian cells
Marc Vogel, Julia E Weigand, Britta Kluge, et al.
EMBO Molecular Medicine
|
October 10, 2013
Gene therapy on the move
Kerstin B Kaufmann, Hildegard Büning, Anne Galy, et al.
Current Gene Therapy
|
June 23, 2007
Advances in the treatment of Chronic Granulomatous Disease by gene therapy
Marion G Ott, Reinhard Seger, Stefan Stein, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
November 4, 2010
Gene therapy of chronic granulomatous disease: the engraftment dilemma
Manuel Grez, Janine Reichenbach, Joachim Schwäble, et al.
Page
of 8